Holds one active US DMF and 2 valid CEPs for meloxicam, filing since 2022. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds one active US DMF and 4 valid CEPs for meloxicam, filing since 2004. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 34 markets.
Holds one active US DMF and 2 valid CEPs for meloxicam, filing since 2004. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 25 markets.
Holds 2 valid CEPs for meloxicam, filing since 2019. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 20 markets.
Holds 2 active US DMFs for meloxicam, filing since 2005. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one valid CEP for meloxicam, filing since 2024. Its 2026 FDA inspection closed as VAI, and its GMP is recognised in 13 markets.
Holds one active US DMF and one valid CEP for meloxicam, filing since 2005. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for meloxicam, filing since 2002. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for meloxicam, filing since 2024. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for meloxicam, filing since 2005. Its GMP is recognised in 5 markets.
Registered with SFDA (Saudi Arabia) for meloxicam.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Meloxicam manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free